Quercetin attenuates fasting and postprandial hyperglycemia in animal models of diabetes mellitus

Nutrition Research and Practice

Volumn 5, Issue 2, 2011, Pages 107-111

  Kim, Ji Hye ^a   Kang, Min Jung ^a   Choi, Ha Neul ^a   Jeong, Soo Mi ^a   Lee, Young Min ^b   Kim, Jung In ^a  

^a Inje University   (South Korea)

^b Inje University College of Medicine   (South Korea)

Author keywords

db db mouse; Glucose; Glycated hemoglobin; Postprandial hyperglycemia; Quercetin

Indexed keywords

ANIMALIA; MUS; RATTUS;

EID: 79956273349     PISSN: 19761457     EISSN: 20056168     Source Type: Journal    
DOI: 10.4162/nrp.2011.5.2.107     Document Type: Article

References (36)

1. Cheng D. Prevalence, predisposition and prevention of type II diabetes. Nutr Metab (Lond) 2005;2:29.
2. American Diabetes Association (ADA). Summary of revisions for the 2008 clinical practice recommendations. Diabetes Care 2008; 31:S3-4.
3. Lorenzati B, Zucco C, Miglietta S, Lamberti F, Bruno G. Oral hypoglycemic drugs: pathophysiological basis of their mechanism of action. Pharmaceuticals 2010;3:3005-20.
4. Adewole SO, Caxton-Martins EA, Ojewole JAO. Protective effect of quercetin on the morphology of pancreatic β-cells of streptozotocintreated diabetic rats. Afr J Tradit Complement Altern Med 2006; 4:64-74.
5. Coskun O, Kanter M, Korkmaz A, Oter S. Quercetin, a flavonoid antioxidant, prevents and protects streptozotocin-induced oxidative stress and β-cell damage in rat pancreas. Pharmacol Res 2005; 51:117-23.
6. Shetty AK, Rashmi R, Rajan MGR, Sambaiah K, Salimath PV. Antidiabetic influence of quercetin in streptozotocin-induced diabetic rats. Nutr Res 2004;24:373-81.
7. Ramachandra R, Shetty AK, Salimath PV. Quercetin alleviates activities of intestinal and renal disaccharidases in streptozotocininduced diabetic rats. Mol Nutr Food Res 2005;49:355-60.
8. Anjaneyulu M, Chopra K. Quercetin, an anti-oxidant bioflavonoid, attenuates diabetic nephropathy in rats. Clin Exp Pharmacol Physiol 2004;31:244-8.
9. Ishikawa A, Yamashita H, Hiemori M, Inagaki E, Kimoto M, Okamoto M, Tsuji H, Memon AN, Mohammadi A, Natori Y. Characterization of inhibitors of postprandial hyperglycemia from the leaves of Nerium indicum. J Nutr Sci Vitaminol (Tokyo) 2007;53:166-73.
10. Jo SH, Ka EH, Lee HS, Apostolidis E, Jang HD, Kwon YI. Comparison of antioxidant potential and rat intestinal α-glucosidases inihibitory activities of quercetin, rutin, and isoquercetin. Int J Appl Res Nat Prod 2009;2:52-60.
11. Standl E, Baumgartl HJ, Füchtenbusch M, Stemplinger J. Effect of acarbose on additional insulin therapy in type 2 diabetic patients with late failure of sulphonylurea therapy. Diabetes Obes Metab 1999;1:215-20.
12. Abrahamson MJ. Optimal glycemic control in type 2 diabetes mellitus: Fasting and postprandial glucose in context. Arch Intern Med 2004;164:486-91.
13. Kim YM, Jeong YK, Wang MH, Lee WY, Rhee HI. Inhibitory effect of pine extract on α-glucosidase activity and postprandial hyperglycemia. Nutrition 2005;21:756-61.
14. Tsujita T, Takaku T. Mechanism of the inhibitory action of chestnut astringent skin extract on carbohydrate absorption. J Nutr Sci Vitaminol (Tokyo) 2008;54:416-21.
15. Akbarzadeh A, Norouzian D, Mehrabi MR, Jamshidi Sh, Farhangi A, Allah Verdi A, Mofidian SMA, Lame Rad B. Induction of diabetes by streptozotocin in rats. Indian J Clin Biochem 2007; 22:60-4.
16. Lee SK, Hwang JY, Song JH, Jo JR, Kim MJ, Kim ME, Kim JI. Inhibitory activity of Euonymus alatus against alphaglucosidase in vitro and in vivo. Nutr Res Pract 2007;1:184-8.
17. Raabo E, Terkildsen TC. On the enzymatic determination of blood glucose. Scand J Clin Lab Invest 1960;12:402-7.
18. Reeves PG, Nielsen FH, Fahey GC Jr. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 1993;123:1939-51.
19. 1c by "high-performance" cation-exchange chromatography. Clin Chem 1980;26:466-72.
20. Morgan CR, Lazarow A. Immunoassay of insulin: two antibody system. Plasma insulin levels in normal, subdiabetic, and diabetic rats. Diabetes 1963;12:115-26.
21. Dahlqvist A. Assay of intestinal disaccharidases. Scand J Clin Lab Invest 1984;44:169-72.
22. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193:265-75.
23. Madar Z. The effect of acarbose and miglitol (BAY-M-1099) on postprandial glucose levels following ingestion of various sources of starch by nondiabetic and streptozotocin-induced diabetic rats. J Nutr 1989;119:2023-29.
24. Kang MJ, Kim JH, Choi HN, Kim MJ, Han JH, Lee JH, Kim JI. Hypoglycemic effects of Welsh onion in animal model of diabetes mellitus. Nutr Res Pract 2010;4:486-91.
25. Ceriello A. Postprandial hyperglycemia and diabetes complications: is it time to treat? Diabetes 2005;54:1-7.
26. Ishida H, Takizawa M, Ozawa S, Nakamichi Y, Yamaguchi S, Katsuta H, Tanaka T, Maruyama M, Katahira H, Yoshimoto K, Itagaki E, Nagamatsu S. Pioglitazone improves insulin secretory capacity and prevents the loss of β-cell mass in obese diabetic db/db mice: possible protection of β cells from oxidative stress. Metabolism 2004;53:488-94.
27. Srinivasan K, Ramarao P. Animal models in type 2 diabetes research: an overview. Indian J Med Res 2007;125:451-72.
28. Hummel KP, Coleman DL, Lane PW. The influence of genetic background on expression of mutations at the diabetes locus in the mouse. I. C57BL/KsJ and C57BL/6J strains. Biochem Genet 1972;7:1-13.
29. Dimitriadis GD, Tessari P, Go VLW, Gerich JE. α-Glucosidase inhibition improves postprandial hyperglycemia and decreases insulin requirements in insulin-dependent diabetes mellitus. Metabolism 1985;34:261-5.
30. Carrascosa JM, Molero JC, Fermín Y, Martínez C, Andrés A, Satrústegui J. Effects of chronic treatment with acarbose on glucose and lipid metabolism in obese diabetic Wistar rats. Diabetes Obes Metab 2001;3:240-8.
31. Kannappan S, Anuradha CV. Insulin sensitizing actions of fenugreek seed polyphenols, quercetin & metformin in a rat model. Indian J Med Res 2009;129:401-8.
32. Juretić D, Bernik Š, Čop L, Hadžija M, Petlevski R, Lukač-Bajalo J. Short-term effect of acarbose on specific intestinal disaccharidase activities and hyperglycaemia in CBA diabetic mice. J Anim Physiol Anim Nutr (Berl) 2003;87:263-8.
33. Lee SM, Bustamante S, Flores C, Bezerra J, Goda T, Koldovský O. Chronic effects of an α-glucosidase inhibitor (Bay o 1248) on intestinal disaccharidase activity in normal and diabetic mice. J Pharmacol Exp Ther 1987;240:132-7.
34. Liu L, Yu YL, Yang JS, Li Y, Liu YW, Liang Y, Liu XD, Xie L, Wang GJ. Berberine suppresses intestinal disaccharidases with beneficial metabolic effects in diabetic states, evidences from in vivo and in vitro study. Naunyn Schmiedebergs Arch Pharmacol 2010;381:371-81.
35. Bressler R, Johnson D. New pharmacological approaches to therapy of NIDDM. Diabetes Care 1992;15:792-805.
36. Theoharides TC, Bielory L. Mast cells and mast cell mediators as targets of dietary supplements. Ann Allergy Asthma Immunol 2004;93:S24-34.